Carregant...
Sodium Iodide Symporter (NIS) in the Management of Patients with Thyroid Carcinoma
Although radioiodine has been applied in thyroid diseases including carcinoma for over 70 years, it was only in 1996 that the basic molecular mechanism of iodine uptake was identified. Iodide is actively transported into the thyroid via a membrane glycoprotein known as sodium iodide symporter (NIS)....
Guardat en:
| Publicat a: | Nucl Med Mol Imaging |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6177348/ https://ncbi.nlm.nih.gov/pubmed/30344779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13139-018-0540-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|